T 2114/13 (Stable polymorphic form of febuxostat/TEIJIN) of 12.10.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T211413.20161012
- Date of decision
- 12 October 2016
- Case number
- T 2114/13
- Petition for review of
- -
- Application number
- 08005934.8
- IPC class
- A61K 31/426A61P 19/06C07D 277/56
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Polymorph of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
- Applicant name
- Teijin Limited
- Opponent name
- Quimica Sintética, S.A.
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 115European Patent Convention Art 56
- Keywords
- Observations by third parties - relevant (no)
Inventive step - unexpected improvement shown
Inventive step - reasonable expectation of success (no) - Catchword
- -
- Cited cases
- T 0777/08
- Citing cases
- T 0041/17
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent with the following claims and a description to be adapted thereto:
claims 1 to 3 filed as main request during the oral proceedings of 12 October 2016.